Halozyme Therapeutics (HALO) Gross Margin Growth (1y) (2011 - 2026)
Halozyme Therapeutics (HALO) Gross Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 372.00 |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | -5.00 |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | -165.00 |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | 236.00 |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | - |
| 10 | Halozyme Therapeutics | 9.83 Bn | 9.51 Bn | 297.47 Mn | -276.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -276.00 |
| Dec 31, 2025 | -332.00 |
| Sep 30, 2025 | 145.00 |
| Jun 30, 2025 | 289.00 |
| Mar 31, 2025 | -381.00 |
| Dec 31, 2024 | 862.00 |
| Sep 30, 2024 | 834.00 |
| Jun 30, 2024 | 553.00 |
| Mar 31, 2024 | 723.00 |
| Dec 31, 2023 | 47.00 |
| Sep 30, 2023 | -273.00 |
| Jun 30, 2023 | -37.00 |
| Mar 31, 2023 | -811.00 |
| Dec 31, 2022 | -204.00 |
| Sep 30, 2022 | -659.00 |
| Jun 30, 2022 | -541.00 |
| Mar 31, 2022 | 689.00 |
| Dec 31, 2021 | 42.00 |
| Sep 30, 2021 | -752.00 |
| Jun 30, 2021 | -647.00 |